American Heart Association responds to sugary drink tax litigation in Santa Cruz
'Big Soda is once again grasping at straws.
'Let's remember how we got here. Back in 2018, stung by multiple losses at the ballot box, this self-serving industry secretly cut a deal that put a 12-year moratorium on sugary drink taxes, aiming to take away the ability of California cities and citizens to raise revenue for important community priorities and to help fight heart disease, stroke and Type 2 diabetes. In 2023, the courts wisely found the penalty provision of the moratorium unconstitutional. Santa Cruz voters stood up for health and passed a sugary drink tax in November, but the beverage industry still won't accept the will of the people.
'The American Heart Association stands with the citizens of Santa Cruz and remains committed to curbing sugary drink consumption and protecting health. The beverage industry stands for profits over health and burdens consumers and taxpayers with billions in needless health care costs, illness and premature death.
'The backroom dealing was wrong in 2018 and it's wrong today. We call on Big Soda and its allies to stop with their lies and this costly litigation.'
###
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.
For Media Inquiries: 214-706-1173
Shelly Hogan: 214-706-1782; [email protected]
For Public Inquiries: 1-800-AHA-USA1 (242-8721)
heart.org and stroke.org
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
Earnings Preview: What to Expect From HP's Report
Valued at a market cap of $24.1 billion, HP Inc. (HPQ) provides personal computing, printing, 3D printing, hybrid work, gaming, and other related technologies. The Palo Alto, California-based company serves individual consumers, small- and medium-sized businesses, and large enterprises. It is expected to announce its fiscal Q3 earnings for 2025 on Wednesday, Aug. 27. Ahead of this event, analysts expect this computer hardware company to report a profit of $0.74 per share, down 10.8% from $0.83 per share in the year-ago quarter. The company has missed Wall Street's earnings estimates in each of the last four quarters. In Q2, HP's EPS of $0.71 fell short of the forecasted figure by 11.3%. More News from Barchart UnitedHealth Stock Spirals Lower Again. Don't Buy the Dip. This Self-Driving Car Stock Is Surging on a Major Nvidia Boost Auto Revenue Keeps Plunging at Tesla. Should You Buy the TSLA Stock Dip or Run Far Away? Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! For fiscal 2025, analysts expect HP to report a profit of $3.09 per share, down 8.6% from $3.38 per share in fiscal 2024. Nonetheless, its EPS is expected to rebound in fiscal 2026, growing by 8.4% year-over-year to $3.35. HP has declined 32.1% over the past 52 weeks, considerably underperforming both the S&P 500 Index's ($SPX) 17.3% return and the Technology Select Sector SPDR Fund's (XLK) 21.1% uptick over the same time frame. On May 28, HP delivered its Q2 results, and its shares plunged 8.3% in the following trading session. Due to strong commercial performance in its personal systems segment, the company's net revenue surged 3.3% year-over-year to $13.2 billion. However, despite the revenue growth, its adjusted EPS of $0.71 fell 13.4% from the year-ago quarter and came in 11.3% below the consensus estimates. This earnings miss might have weighed on investor sentiment. Wall Street analysts are cautious about HPQ's stock, with an overall 'Hold" rating. Among 14 analysts covering the stock, three recommend "Strong Buy," 10 indicate "Hold," and one advises a "Strong Sell' rating. The mean price target for HPQ is $27.55, indicating a 7.2% premium from the current levels. On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 minutes ago
- Yahoo
TriNet: Q2 Earnings Snapshot
DUBLIN, Calif. (AP) — DUBLIN, Calif. (AP) — TriNet Group Inc. (TNET) on Friday reported second-quarter profit of $37 million. On a per-share basis, the Dublin, California-based company said it had net income of 76 cents. Earnings, adjusted for one-time gains and costs, came to $1.15 per share. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1 per share. The human resources services outsourcing company posted revenue of $1.24 billion in the period. Its adjusted revenue was $291 million, also beating Street forecasts. Three analysts surveyed by Zacks expected $283.7 million. TriNet expects full-year earnings in the range of $3.25 to $4.75 per share. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on TNET at
Yahoo
5 minutes ago
- Yahoo
What to Expect From Cooper Companies' Q3 2025 Earnings Report
San Ramon, California-based The Cooper Companies, Inc. (COO) develops, manufactures, and markets contact lens wearers. Valued at a market cap of $14.8 billion, the company also focuses on family and women's health care, providing fertility products and services, medical devices, contraception, and cryostorage to health care professionals and patients. It is scheduled to announce its fiscal Q3 earnings for 2025 after the market closes on Wednesday, Aug. 27. Before this event, analysts project this vision and women's healthcare company to report a profit of $1.06 per share, up 10.4% from $0.96 per share in the year-ago quarter. The company has met or surpassed Wall Street's bottom-line estimates in each of the last four quarters. Its earnings of $0.96 per share in the previous quarter outpaced the consensus estimates by 3.2%. More News from Barchart UnitedHealth Stock Spirals Lower Again. Don't Buy the Dip. This Self-Driving Car Stock Is Surging on a Major Nvidia Boost Auto Revenue Keeps Plunging at Tesla. Should You Buy the TSLA Stock Dip or Run Far Away? Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! For the full year, analysts expect COO to report EPS of $4.06, up 10% from $3.69 per share in fiscal 2024. Furthermore, its EPS is expected to grow 9.9% year-over-year to $4.46 in fiscal 2026. Shares of COO have declined 19.8% over the past 52 weeks, lagging behind both the S&P 500 Index's ($SPX) 17.3% uptick and the Health Care Select Sector SPDR Fund's (XLV) 9.4% drop over the same time frame. Despite delivering better-than-expected Q2 results on May 29, shares of COO plunged 14.6% in the following trading session. Due to growth in both of its reportable segments, the company's overall revenue improved 6.3% year-over-year to $1 billion, exceeding consensus expectations. Moreover, its adjusted EPS of $0.96 advanced 12.9% from the year-ago quarter, topping analyst estimates by 3.2%. Wall Street analysts are moderately optimistic about COO's stock, with an overall "Moderate Buy" rating. Among 15 analysts covering the stock, 10 recommend "Strong Buy," one indicates a "Moderate Buy," and four advise 'Hold.' The mean price target for COO is $92.93, implying a 25.9% premium from the current levels. On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
